Sethuraman Natarajan

Officer at TRDA

Sold, on record
$1.9M
Dollars the filings state
Form 4 sales
10
Latest May 4, 2026
Form 144 notices
6
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • TRDAEntrada Therapeutics, Inc.Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice TRDANotice
    Oct 16, 2024 2024

    Filed to sell 20,057 shares ($352k)

    Sethuraman Natarajan, Officer

    10b5-1 plan5.1x usual sizeFiling

  2. 2 Form 4 sale TRDARoutine
    Oct 16, 2024 same day

    Sold 600 shares at $18.00 ($11k)

    Sethuraman Natarajan, President, Research & Develop.

    10b5-1 planSold 0.3% of holdings ($3.3M position)183,216 shares left0.2x usual sizeFollows a Form 144Filing

  3. 3 Form 4 sale TRDAUnusual
    Nov 6, 2024 +21 days

    Sold 18,219 shares at $18.62 ($339k)

    Sethuraman Natarajan, President, Research & Develop.

    10b5-1 planSold 9.9% of holdings ($3.4M position)164,997 shares left5.1x usual sizeFollows a Form 144Filing

  4. 4 Form 144 notice TRDANotice
    Nov 11, 2024 +5 days

    Filed to sell 18,762 shares ($372k)

    Sethuraman Natarajan, Officer

    10b5-1 plan4.7x usual sizeFiling

  5. 5 Form 4 sale TRDARoutine
    Nov 13, 2024 +2 days

    Sold 4,109 shares at $20.03 ($82k)

    Sethuraman Natarajan, President, Research & Develop.

    10b5-1 planSold 2.5% of holdings ($3.3M position)160,888 shares left1x usual sizeFollows a Form 144Filing

  6. 6 Form 4 sale TRDAUnusual
    Dec 3, 2024 +20 days

    Sold 15,891 shares at $20.18 ($321k)

    Sethuraman Natarajan, President, Research & Develop.

    10b5-1 planSold 9.9% of holdings ($3.2M position)144,997 shares left3.9x usual sizeFollows a Form 144Filing

  7. 7 Form 144 notice TRDANotice
    May 4, 2026 +517 days

    Filed to sell 25,907 shares ($376k)

    Sethuraman Natarajan, Officer

    10b5-1 plan6.3x usual sizeFiling

  8. 8 Form 4 sale TRDAUnusual
    May 4, 2026 same day

    Sold 25,907 shares at $15.39 ($399k)

    Sethuraman Natarajan, President, Research & Develop.

    10b5-1 planSold 10.7% of holdings ($3.7M position)216,317 shares left6.3x usual sizeFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (16)

Form 144 notices and Form 4 sales by Sethuraman Natarajan
Source
May 4, 2026May 4, 2026TRDAPresident, Research & Develop.Form 4 sale25,907$399k10.7%UnusualSEC
May 4, 2026May 4, 2026TRDAOfficerForm 144 notice25,907$376kNoticeSEC
Dec 3, 2024Dec 3, 2024TRDAPresident, Research & Develop.Form 4 sale15,891$321k9.9%UnusualSEC
Nov 13, 2024Nov 13, 2024TRDAPresident, Research & Develop.Form 4 sale4,109$82k2.5%RoutineSEC
Nov 11, 2024Nov 12, 2024TRDAOfficerForm 144 notice18,762$372kNoticeSEC
Nov 6, 2024Nov 6, 2024TRDAPresident, Research & Develop.Form 4 sale18,219$339k9.9%UnusualSEC
Oct 16, 2024Oct 18, 2024TRDAPresident, Research & Develop.Form 4 sale600$11k0.3%RoutineSEC
Oct 16, 2024Oct 16, 2024TRDAOfficerForm 144 notice20,057$352kNoticeSEC
Sep 9, 2024Sep 10, 2024TRDAChief Scientific OfficerForm 4 sale3,242$49k1.7%RoutineSEC
Jul 15, 2024Jul 16, 2024TRDAChief Scientific OfficerForm 4 sale1,238$22k0.7%RoutineSEC
Jul 12, 2024Jul 12, 2024TRDAOfficerForm 144 notice20,057$348kNoticeSEC
May 20, 2024May 20, 2024TRDAChief Scientific OfficerForm 4 sale18,980$288k9.1%RoutineSEC
May 16, 2024May 16, 2024TRDAOfficerForm 144 notice18,980$275kNoticeSEC
Jul 11, 2023Jul 12, 2023TRDAChief Scientific OfficerForm 4 sale17,878$322k10.4%RoutineSEC
Apr 17, 2023Apr 19, 2023TRDAChief Scientific OfficerForm 4 sale3,961$71k2.3%RoutineSEC
Apr 17, 2023Apr 17, 2023TRDAOfficerForm 144 notice21,839$377kNoticeSEC